Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReOpen2: OPN-375 in Chronic Rhinosinusitis Without Nasal Polyps
NCT03960580Phase 3Completed
- Sponsor
- OptiNose
- Start
- Jun 2019
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of fluticasone propionate in chronic rhinosinusitis without nasal polyps (CRSsNP), sponsored by OptiNose. Started Jun 2019; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic rhinosinusitis without nasal polyps (CRSsNP)
Beyond the preview
Go deeper on NCT03960580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960580.